| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Director
1 company
Hoer Michael A. serves as a Director at MED. Across recent SEC filings that breaks down to 6 buys and 0 sells. Those positions are worth an estimated $305K at current prices.
Historically, Hoer Michael A.'s trades have earned a below-average insider score of 26/100 across 5 rated trades. Over a 12-month horizon, 0.0% of those trades were profitable, with an average 12-month return of -62.5%.
The biggest single holding is MED (~$305K) as Director. Net of sales, the recent Form 4 record there shows accumulation of 320 shares.
| Date | Ticker | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| Nov 7, 2023 | MED Medifast Inc | Director | Buy | 50 | $68.89 | $3,428.24 | +0.6% | -25.0% | -71.4% | |
| Aug 8, 2023 | MED Medifast Inc | Director | Buy | 38 | $89.42 | $3,366.13 | +0.5% | -21.0% | -77.7% | |
| May 9, 2023 | MED Medifast Inc | Director | Buy | 13 | $87.50 | $1,117.55 | +0.2% | +9.8% | -71.5% | |
| Feb 7, 2023 | MED Medifast Inc | Director | Buy | 10 | $114.97 | $1,095.09 | +0.2% | -22.0% | -53.0% | |
| Nov 8, 2022 | MED Medifast Inc | Director | Buy | 10 | $106.93 | $1,078.60 | +0.2% | +3.9% | -38.9% | |
| Nov 12, 2018 | MED Medifast Inc | Director | Buy | 200 | $156.23 | $31,246.00 | +50.0% | - | - |